Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 104 entries
Sorted by: Best Match Show Resources per page
[Advances in nephrology].

Polskie Archiwum Medycyny Wewnetrznej

Siciński A.
PMID: 4865248
Pol Arch Med Wewn. 1967;38(4):543-9.

No abstract available.

Cite
Siciński A. Postepy nefrologii. [Advances in nephrology]. Pol Arch Med Wewn. 1967;38(4):543-9
Siciński, A. (1967). Postepy nefrologii. [Advances in nephrology]. Polskie Archiwum Medycyny Wewnetrznej, 38(4), 543-9.
Siciński, A. "Postepy nefrologii." [Advances in nephrology]. Polskie Archiwum Medycyny Wewnetrznej vol. 38,4 (1967): 543-9.
Siciński A. Postepy nefrologii. [Advances in nephrology]. Pol Arch Med Wewn. 1967;38(4):543-9. Polish. PMID: 4865248.
Copy Download .nbib Format: NLM
[Post-traumatic myocardial infarction complicated by rupture of the ventricular septum].

Pediatria polska

Lorkiewicz Z, Gielwanowski H, Kaczmarek J, Mielczarek H, Sapiński A.
PMID: 5531812
Pediatr Pol. 1970 Dec;45(12):1501-4.

No abstract available.

Cite
Lorkiewicz Z, Gielwanowski H, Kaczmarek J, et al. Zawał pourazowy serca powikłany peknieciem przegrody miedzykomorowej. [Post-traumatic myocardial infarction complicated by rupture of the ventricular septum]. Pediatr Pol. 1970;45(12):1501-4
Lorkiewicz, Z., Gielwanowski, H., Kaczmarek, J., Mielczarek, H., & Sapiński, A. (1970). Zawał pourazowy serca powikłany peknieciem przegrody miedzykomorowej. [Post-traumatic myocardial infarction complicated by rupture of the ventricular septum]. Pediatria polska, 45(12), 1501-4.
Lorkiewicz, Z, et al. "Zawał pourazowy serca powikłany peknieciem przegrody miedzykomorowej." [Post-traumatic myocardial infarction complicated by rupture of the ventricular septum]. Pediatria polska vol. 45,12 (1970): 1501-4.
Lorkiewicz Z, Gielwanowski H, Kaczmarek J, Mielczarek H, Sapiński A. Zawał pourazowy serca powikłany peknieciem przegrody miedzykomorowej. [Post-traumatic myocardial infarction complicated by rupture of the ventricular septum]. Pediatr Pol. 1970 Dec;45(12):1501-4. Polish. PMID: 5531812.
Copy Download .nbib Format: NLM
Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model.

Experimental and therapeutic medicine

Wiciński M, Malinowski B, Węclewicz MM, Grześk E, Grześk G.
PMID: 28565810
Exp Ther Med. 2017 May;13(5):2071-2078. doi: 10.3892/etm.2017.4180. Epub 2017 Mar 02.

Resveratrol (3, 4', 5-trihydroxy-trans-stilbene) is a natural, non-flavonoid polyphenol that exerts protective properties against atherosclerosis-associated endothelial dysfunction and senescence. The present study aimed to assess the influence of resveratrol on vascular contractility and molecular factors including sirtuin-1 (SIRT1), adiponectin...

Cite
Wiciński M, Malinowski B, Węclewicz MM, et al. Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model. Exp Ther Med. 2017;13(5):2071-2078doi: 10.3892/etm.2017.4180.
Wiciński, M., Malinowski, B., Węclewicz, M. M., Grześk, E., & Grześk, G. (2017). Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model. Experimental and therapeutic medicine, 13(5), 2071-2078. https://doi.org/10.3892/etm.2017.4180
Wiciński, Michał, et al. "Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model." Experimental and therapeutic medicine vol. 13,5 (2017): 2071-2078. doi: https://doi.org/10.3892/etm.2017.4180
Wiciński M, Malinowski B, Węclewicz MM, Grześk E, Grześk G. Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model. Exp Ther Med. 2017 May;13(5):2071-2078. doi: 10.3892/etm.2017.4180. Epub 2017 Mar 02. PMID: 28565810; PMCID: PMC5443311.
Copy Download .nbib Format: NLM
Bilateral Perthes' disease.

Ortopedia, traumatologia, rehabilitacja

Grzegorzewski A, Synder M, Szymczak W, Kozłowski P, Sibiński M.
PMID: 17618204
Ortop Traumatol Rehabil. 2004 Oct 30;6(5):567-74.

Background. Most patients who develop Perthes disease have unilateral hip involvement. Bilateral involvement occurs in approximately 8-24% of cases. The purpose of this study was to compare the development and outcome of bilateral disease in two groups of patients,...

Cite
Grzegorzewski A, Synder M, Szymczak W, et al. Bilateral Perthes' disease. Ortop Traumatol Rehabil. 2004;6(5):567-74
Grzegorzewski, A., Synder, M., Szymczak, W., Kozłowski, P., & Sibiński, M. (2004). Bilateral Perthes' disease. Ortopedia, traumatologia, rehabilitacja, 6(5), 567-74.
Grzegorzewski, Andrzej, et al. "Bilateral Perthes' disease." Ortopedia, traumatologia, rehabilitacja vol. 6,5 (2004): 567-74.
Grzegorzewski A, Synder M, Szymczak W, Kozłowski P, Sibiński M. Bilateral Perthes' disease. Ortop Traumatol Rehabil. 2004 Oct 30;6(5):567-74. PMID: 17618204.
Copy Download .nbib Format: NLM
The genus Microserangium Miyatake (Coleoptera, Coccinellidae) from China.

ZooKeys

Wang X, Slipiński A, Ren S.
PMID: 24363587
Zookeys. 2013 Dec 05;(359):13-33. doi: 10.3897/zookeys.359.6057. eCollection 2013.

The genus Microserangium Chapinfrom China is reviewed. Nine species are recognized, including seven new species: M. erythrinum Wang & Ren, sp. n., M. fuscum Wang & Ren, sp. n., M. glossoides Wang & Ren, sp. n., M. shennongensis Wang...

Cite
Wang X, Slipiński A, Ren S. The genus Microserangium Miyatake (Coleoptera, Coccinellidae) from China. Zookeys. 2013;(359):13-33doi: 10.3897/zookeys.359.6057.
Wang, X., Slipiński, A., & Ren, S. (2013). The genus Microserangium Miyatake (Coleoptera, Coccinellidae) from China. ZooKeys, (359), 13-33. https://doi.org/10.3897/zookeys.359.6057
Wang, Xingmin, et al. "The genus Microserangium Miyatake (Coleoptera, Coccinellidae) from China." ZooKeys vol. ,359 (2013): 13-33. doi: https://doi.org/10.3897/zookeys.359.6057
Wang X, Slipiński A, Ren S. The genus Microserangium Miyatake (Coleoptera, Coccinellidae) from China. Zookeys. 2013 Dec 05;(359):13-33. doi: 10.3897/zookeys.359.6057. eCollection 2013. PMID: 24363587; PMCID: PMC3867173.
Copy Download .nbib Format: NLM
Phenomenon of painless knee in recurrent patellar dislocation in children.

Archives of medical science : AMS

Masłoń A, Witoński D, Modrzewski T, Grabicki M, Sibiński M, Grzegorzewski A.
PMID: 25097585
Arch Med Sci. 2014 Jun 29;10(3):531-6. doi: 10.5114/aoms.2014.43747. Epub 2014 Jun 27.

INTRODUCTION: Cartilage lesion with patellar malalignment may be correlated with pain. Situations in which patients with recurrent patellar dislocation are painless between episodes of luxation can be approached with considerable curiosity. We evaluated the distribution of substance-P and S-100...

Cite
Masłoń A, Witoński D, Modrzewski T, et al. Phenomenon of painless knee in recurrent patellar dislocation in children. Arch Med Sci. 2014;10(3):531-6doi: 10.5114/aoms.2014.43747.
Masłoń, A., Witoński, D., Modrzewski, T., Grabicki, M., Sibiński, M., & Grzegorzewski, A. (2014). Phenomenon of painless knee in recurrent patellar dislocation in children. Archives of medical science : AMS, 10(3), 531-6. https://doi.org/10.5114/aoms.2014.43747
Masłoń, Adrian, et al. "Phenomenon of painless knee in recurrent patellar dislocation in children." Archives of medical science : AMS vol. 10,3 (2014): 531-6. doi: https://doi.org/10.5114/aoms.2014.43747
Masłoń A, Witoński D, Modrzewski T, Grabicki M, Sibiński M, Grzegorzewski A. Phenomenon of painless knee in recurrent patellar dislocation in children. Arch Med Sci. 2014 Jun 29;10(3):531-6. doi: 10.5114/aoms.2014.43747. Epub 2014 Jun 27. PMID: 25097585; PMCID: PMC4107259.
Copy Download .nbib Format: NLM
PCSK9 signaling pathways and their potential importance in clinical practice.

The EPMA journal

Wiciński M, Żak J, Malinowski B, Popek G, Grześk G.
PMID: 29209441
EPMA J. 2017 Aug 14;8(4):391-402. doi: 10.1007/s13167-017-0106-6. eCollection 2017 Dec.

In the following review, authors described the structure and biochemical pathways of PCSK9, its involvement in LDL metabolism, as well as significances of proprotein convertase subtilisin/kexin type 9 targeted treatment. PCSK9 is a proprotein convertase, which plays a crucial...

Cite
Wiciński M, Żak J, Malinowski B, et al. PCSK9 signaling pathways and their potential importance in clinical practice. EPMA J. 2017;8(4):391-402doi: 10.1007/s13167-017-0106-6.
Wiciński, M., Żak, J., Malinowski, B., Popek, G., & Grześk, G. (2017). PCSK9 signaling pathways and their potential importance in clinical practice. The EPMA journal, 8(4), 391-402. https://doi.org/10.1007/s13167-017-0106-6
Wiciński, Michał, et al. "PCSK9 signaling pathways and their potential importance in clinical practice." The EPMA journal vol. 8,4 (2017): 391-402. doi: https://doi.org/10.1007/s13167-017-0106-6
Wiciński M, Żak J, Malinowski B, Popek G, Grześk G. PCSK9 signaling pathways and their potential importance in clinical practice. EPMA J. 2017 Aug 14;8(4):391-402. doi: 10.1007/s13167-017-0106-6. eCollection 2017 Dec. PMID: 29209441; PMCID: PMC5700013.
Copy Download .nbib Format: NLM
Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review.

Diagnostics (Basel, Switzerland)

Malinowski B, Wiciński M, Musiała N, Osowska I, Szostak M.
PMID: 31731466
Diagnostics (Basel). 2019 Oct 25;9(4). doi: 10.3390/diagnostics9040161.

Prostate cancer (PCa) is one of the most common cancers in men that usually develops slowly. Since diagnostic methods improved in the last decade and are highly precise, more cancers are diagnosed at an early stage. Active surveillance or...

Cite
Malinowski B, Wiciński M, Musiała N, et al. Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review. Diagnostics (Basel). 2019;9(4)doi: 10.3390/diagnostics9040161.
Malinowski, B., Wiciński, M., Musiała, N., Osowska, I., & Szostak, M. (2019). Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review. Diagnostics (Basel, Switzerland), 9(4), . https://doi.org/10.3390/diagnostics9040161
Malinowski, Bartosz, et al. "Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review." Diagnostics (Basel, Switzerland) vol. 9,4 (2019). doi: https://doi.org/10.3390/diagnostics9040161
Malinowski B, Wiciński M, Musiała N, Osowska I, Szostak M. Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review. Diagnostics (Basel). 2019 Oct 25;9(4). doi: 10.3390/diagnostics9040161. PMID: 31731466; PMCID: PMC6963205.
Copy Download .nbib Format: NLM
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.

Cancer cell

Hinohara K, Wu HJ, Sébastien Vigneau, McDonald TO, Igarashi KJ, Yamamoto KN, Madsen T, Fassl A, Egri SB, Papanastasiou M, Ding L, Peluffo G, Cohen O, Kales SC, Lal-Nag M, Rai G, Maloney DJ, Jadhav A, Simeonov A, Wagle N, Brown M, Meissner A, Sicinski P, Jaffe JD, Jeselsohn R, Gimelbrant AA, Michor F, Polyak K.
PMID: 30753830
Cancer Cell. 2019 Feb 11;35(2):330-332. doi: 10.1016/j.ccell.2019.01.012.

No abstract available.

Cite
Hinohara K, Wu HJ, Sébastien Vigneau, et al. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell. 2019;35(2):330-332doi: 10.1016/j.ccell.2019.01.012.
Hinohara, K., Wu, H. J., Sébastien Vigneau, McDonald, T. O., Igarashi, K. J., Yamamoto, K. N., Madsen, T., Fassl, A., Egri, S. B., Papanastasiou, M., Ding, L., Peluffo, G., Cohen, O., Kales, S. C., Lal-Nag, M., Rai, G., Maloney, D. J., Jadhav, A., Simeonov, A., Wagle, N., Brown, M., Meissner, A., Sicinski, P., Jaffe, J. D., Jeselsohn, R., Gimelbrant, A. A., Michor, F., & Polyak, K. (2019). KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer cell, 35(2), 330-332. https://doi.org/10.1016/j.ccell.2019.01.012
Hinohara, Kunihiko, et al. "KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance." Cancer cell vol. 35,2 (2019): 330-332. doi: https://doi.org/10.1016/j.ccell.2019.01.012
Hinohara K, Wu HJ, Sébastien Vigneau, McDonald TO, Igarashi KJ, Yamamoto KN, Madsen T, Fassl A, Egri SB, Papanastasiou M, Ding L, Peluffo G, Cohen O, Kales SC, Lal-Nag M, Rai G, Maloney DJ, Jadhav A, Simeonov A, Wagle N, Brown M, Meissner A, Sicinski P, Jaffe JD, Jeselsohn R, Gimelbrant AA, Michor F, Polyak K. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell. 2019 Feb 11;35(2):330-332. doi: 10.1016/j.ccell.2019.01.012. PMID: 30753830; PMCID: PMC6428693.
Copy Download .nbib Format: NLM
Influence of Benzo(a)pyrene on Different Epigenetic Processes.

International journal of molecular sciences

Bukowska B, Sicińska P.
PMID: 34948252
Int J Mol Sci. 2021 Dec 15;22(24). doi: 10.3390/ijms222413453.

Epigenetic changes constitute one of the processes that is involved in the mechanisms of carcinogenicity. They include dysregulation of DNA methylation processes, disruption of post-translational patterns of histone modifications, and changes in the composition and/or organization of chromatin. Benzo(a)pyrene...

Cite
Bukowska B, Sicińska P. Influence of Benzo(a)pyrene on Different Epigenetic Processes. Int J Mol Sci. 2021;22(24)doi: 10.3390/ijms222413453.
Bukowska, B., & Sicińska, P. (2021). Influence of Benzo(a)pyrene on Different Epigenetic Processes. International journal of molecular sciences, 22(24), . https://doi.org/10.3390/ijms222413453
Bukowska, Bożena, and Sicińska, Paulina. "Influence of Benzo(a)pyrene on Different Epigenetic Processes." International journal of molecular sciences vol. 22,24 (2021). doi: https://doi.org/10.3390/ijms222413453
Bukowska B, Sicińska P. Influence of Benzo(a)pyrene on Different Epigenetic Processes. Int J Mol Sci. 2021 Dec 15;22(24). doi: 10.3390/ijms222413453. PMID: 34948252.
Copy Download .nbib Format: NLM
Influence of Benzo(a)pyrene on Different Epigenetic Processes.

International journal of molecular sciences

Bukowska B, Sicińska P.
PMID: 34948252
Int J Mol Sci. 2021 Dec 15;22(24). doi: 10.3390/ijms222413453.

Epigenetic changes constitute one of the processes that is involved in the mechanisms of carcinogenicity. They include dysregulation of DNA methylation processes, disruption of post-translational patterns of histone modifications, and changes in the composition and/or organization of chromatin. Benzo(a)pyrene...

Cite
Bukowska B, Sicińska P. Influence of Benzo(a)pyrene on Different Epigenetic Processes. Int J Mol Sci. 2021;22(24)doi: 10.3390/ijms222413453.
Bukowska, B., & Sicińska, P. (2021). Influence of Benzo(a)pyrene on Different Epigenetic Processes. International journal of molecular sciences, 22(24), . https://doi.org/10.3390/ijms222413453
Bukowska, Bożena, and Sicińska, Paulina. "Influence of Benzo(a)pyrene on Different Epigenetic Processes." International journal of molecular sciences vol. 22,24 (2021). doi: https://doi.org/10.3390/ijms222413453
Bukowska B, Sicińska P. Influence of Benzo(a)pyrene on Different Epigenetic Processes. Int J Mol Sci. 2021 Dec 15;22(24). doi: 10.3390/ijms222413453. PMID: 34948252; PMCID: PMC8707600.
Copy Download .nbib Format: NLM
Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.

Nature

Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, Tan Y, Ci Y, Wu F, Dai X, Guo J, Huang YH, Fan C, Ren S, Sun Y, Freeman GJ, Sicinski P, Wei W.
PMID: 31270456
Nature. 2019 Jul;571(7766):E10. doi: 10.1038/s41586-019-1351-8.

An Amendment to this paper has been published and can be accessed via a link at the top of the paper. The original Letter has not been corrected.

Cite
Zhang J, Bu X, Wang H, et al. Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2019;571(7766):E10doi: 10.1038/s41586-019-1351-8.
Zhang, J., Bu, X., Wang, H., Zhu, Y., Geng, Y., Nihira, N. T., Tan, Y., Ci, Y., Wu, F., Dai, X., Guo, J., Huang, Y. H., Fan, C., Ren, S., Sun, Y., Freeman, G. J., Sicinski, P., & Wei, W. (2019). Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature, 571(7766), E10. https://doi.org/10.1038/s41586-019-1351-8
Zhang, Jinfang, et al. "Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance." Nature vol. 571,7766 (2019): E10. doi: https://doi.org/10.1038/s41586-019-1351-8
Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira NT, Tan Y, Ci Y, Wu F, Dai X, Guo J, Huang YH, Fan C, Ren S, Sun Y, Freeman GJ, Sicinski P, Wei W. Author Correction: Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2019 Jul;571(7766):E10. doi: 10.1038/s41586-019-1351-8. PMID: 31270456.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 104 entries